5β,19-Epoxycucurbitane triterpenoids from momordica charantia and their anti-inflammatory and cytotoxic activity

Planta Medica

Volumn 81, Issue 1, 2015, Pages 62-70

  Liaw, Chia Ching ^a   Huang, Hui Chi ^b   Hsiao, Ping Chun ^c,d   Zhang, Li Jie ^c   Lin, Zhi Hu ^c   Hwang, Syh Yuan ^d   Hsu, Feng Lin ^e   Kuo, Yao Haur ^b,c,e  

^a Starsci Biotech Co Ltd   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^d ENDEMIC SPECIES RESEARCH INSTITUTE   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

5 ,19 epoxycucurbitane; Anti inflammatory activity; Cucurbitaceae; Cytotoxicity; Momordica charantia; Taikuguasins

Indexed keywords

5BETA,19 EPOXY 25 METHOXYCUCURBITA 6,23 DIENE 3BETA,19 DIOL; 5BETA,19 EPOXYCUCURBITANE TRITERPENOID DERIVATIVE; ALCOHOL; MOMORDICA CHARANTIA EXTRACT; NITRIC OXIDE; TAIKUGAUSIN A; TAIKUGAUSIN B; TAIKUGAUSIN C; TAIKUGAUSIN D; TAIKUGAUSIN E; TRITERPENOID; UNCLASSIFIED DRUG; 5BETA,19-EPOXYCUCURBITANE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; SAPONINS; TRITERPENES;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; CYTOTOXICITY; DRUG ISOLATION; FRUIT; HETERONUCLEAR MULTIPLE BOND CORRELATION; HETERONUCLEAR MULTIPLE QUANTUM COHERENCE; HUMAN; HUMAN CELL; MOMORDICA CHARANTIA; NUCLEAR MAGNETIC RESONANCE; NUCLEAR OVERHAUSER EFFECT; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR CELL LINE; TWO DIMENSIONAL NUCLEAR MAGNETIC RESONANCE; ANIMALS; CHEMISTRY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EFFECTS; DRUG EVALUATION, PRECLINICAL; HEP G2 CELLS; HUMANS; MACROPHAGES; MAGNETIC RESONANCE SPECTROSCOPY; METABOLISM; MICE; MOLECULAR STRUCTURE;

CUCURBITACEAE; MOMORDICA CHARANTIA;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HEP G2 CELLS; HUMANS; MACROPHAGES; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MOLECULAR STRUCTURE; MOMORDICA CHARANTIA; NITRIC OXIDE; SAPONINS; TRITERPENES;

EID: 84919372507     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0034-1383307     Document Type: Article

References (25)

1. Grover JK, Yadav SP. Pharmacological actions and potential uses of Momordica charantia: a review. J Ethnopharmacol 2004; 93: 123-132
2. Abascal K, Yarnell E. Using bitter melon to treat diabetes. J Altern Complement Med 2005; 1: 179-184
3. Bourinbaiar AS, Lee-Huang S. Potentiation of anti-HIV activity of anti-inflammatory drugs, dexamethasone and indomethacin, by MAP30, the antiviral agent from bitter melon. Biochem Biophys Res Commun 1995; 208: 779-785
4. Jilka C, Strifler B, Fortner GW, Hays EF, Takemoto DJ. In vivo antitumor activity of the bitter melon (Momordica charantia). Cancer Res 1983; 43: 5151-5155
5. Ray RB, Raychoudhuri A, Steele R, Nerurkar P. Bitter melon ( Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis. Cancer Res 2010; 70: 1925-1931
6. Ali L, Khan AK, Mamun MI, Mosihuzzaman M, Nahar N, Nur-e-Alam M, Rokeya B. Studies on hypoglycemic effects of fruit pulp, seed, and whole plant of Momordica charantia on normal and diabetic model rats. Planta Med 1993; 59: 408-412
7. Kumar R, Balaji S, Uma TS, Sehgal PK. Fruit extracts of Momordica charantia potentiate glucose uptake and up-regulate Glut-4, PPAR gamma and PI3K. J Ethnopharmacol 2009; 126: 533-537
8. Gurbuz I, Akyuz C, Yesilada E, Sener B. Anti-ulcerogenic effect of Momordica charantia L. fruits on various ulcer models in rats. J Ethnopharmacol 2000; 71: 77-82
9. Li CK, Chen HW, Yun WT, Liu KL. Suppressive effects of wild bitter gourd (Momordica charantia Linn. var. abbreviata ser.) fruit extracts on inflammatory responses in RAW264.7 macrophages. J Ethnopharmacol 2009; 122: 227-233
10. Leung SO, Yeung HW, Leung KN. The immunosuppressive activities of two abortifacient proteins isolated from the seeds of bitter melon (Momordica charantia). Immunopharmacology 1987; 13: 159-171
11. Lee SY, Eom SH, Kim YK, Park NI, Park SU. Cucurbitane-type triterpenoids in Momordica charantia Linn. J Med Plants Res 2009; 3: 1264-1269
12. Murakami T, Emoto A, Matsuda H, Yoshikawa M. Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica charantia L. Chem Pharm Bull 2001; 49: 54-63
13. Begum S, Ahmed M, Siddiqui BS. Triterpenes, a sterol and a monocyclic alcohol from Momordica charantia L. Phytochemistry 1997; 44: 1313-1320
14. Chen JC, Chiu MH, Nie RL, Cordell GA, Qiu SX. Cucurbitacins and cucurbitane glycosides: structures and biological activities. Nat Prod Rep 2005; 22: 386-399
15. Hsiao PC, Liaw CC, Hwang SY, Cheng HL, Zhang LJ, Shen CC, Hsu FL, Kuo YH. Antiproliferative and hypoglycemic cucurbitane-type glycosides from the fruits of Momordica charantia. J Agric Food Chem 2013; 61: 2979-2986
16. Zhang LJ, Liaw CC, Hsiao PC, Huang HC, Lin MJ, Lin ZH, Hsu FL, Kuo YH. Cucurbitane-type glycosides from the fruits of Momordica charantia and their hypoglycaemic and cytotoxic activities. J Funct Foods 2014; 564-574
17. Mulholland DA, Sewram V, Osborne R, Pegel KH, Connolly JD. Cucurbitane triterpenoids from the leaves of Momordica foetida. Phytochemistry 1997; 45: 391-395
18. Li QY, Chen HB, Liu ZM, Wang B, Zhao YY. Cucurbitane triterpenoids from Momordica charantia. Magn Reson Chem 2007; 45: 451-456
19. Akihisa T, Higo N, Tokuda H, Ukiya M, Akazawa H, Tochigi Y, Kimura Y, Suzuki T, Nishino H. Cucurbitane-type triterpenoids from the fruits of Momordica charantia and their cancer chemopreventive effects. J Nat Prod 2007; 70: 1233-1239
20. Chen JC, Liu WQ, Lu L, Qiu MH, Zheng YT, Yang LM, Zhang XM, Zhou L, Li ZR. Kuguacins F-S, cucurbitane triterpenoids from Momordica charantia. Phytochemistry 2009; 70: 133-140
21. Nguyen XN, Phan VK, Chau VM, Ninh KB, Nguyen XC, Lee MH, Bui HT, Tran HQ, Nguyen HT, Kim YH. Cucurbitane-type triterpene glycosides from the fruits of Momordica charantia. Magn Reson Chem 2010; 48: 392-396
22. Pan ZM, Cheng JT, He J, Wang YY, Peng LY, Xu G, Sun WB, Zhao QS. Splendidins A-C, three new clerodane diterpenoids from Salvia splendens. Helv Chim Acta 2011; 94: 417-422
23. Fukui S, Hochster RM. D-ribo-Hexos-3-ulose, a new dicarbonyl-sugar. J Am Chem Soc 1963; 85: 1967-1968
24. Harinantenaina L, Tanaka M, Takaoka S, Oda M, Mogami O, Uchida M, Asakawa Y. Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chem Pharm Bull 2006; 54: 1017-1021
25. Zhang LJ, Chiou CT, Cheng JJ, Huang HC, Kuo-Yang LM, Liao CC, Bastow KF, Lee KH, Kuo YH. Cytotoxic polyisoprenyl benzophenonoids from Garcinia subelliptica. J Nat Prod 2010; 73: 557-562